Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Frontiers in Endocrinology|August 14, 2023
Fibroblast growth factor 21 in metabolic syndromeMing Yang, Chongbin Liu, Na Jiang, et al.
Frontiers in Pharmacology|July 3, 2023
Mitochondrial homeostasis: a potential target for delaying renal agingMing Yang, Chongbin Liu, Na Jiang, et al.
Frontiers in Endocrinology|March 8, 2021
MAMs Protect Against Ectopic Fat Deposition and Lipid-Related Kidney Damage in DN PatientsMing Yang, Yachun Han, Shilu Luo, et al.
Frontiers in Endocrinology|June 8, 2023
Myostatin: a potential therapeutic target for metabolic syndromeMing Yang, Chongbin Liu, Na Jiang, et al.
Journal of the American Society of Nephrology : JASN|January 21, 2026
PACS-2 Alleviates Kidney Fibrosis by Inhibiting Tubular Epithelial Cell G2/M Arrest through CDKL1 KinaseChenrui Li, Yan Liu, Hao Zhao, et al.
Frontiers in Endocrinology|June 29, 2023
Endoplasmic reticulum homeostasis: a potential target for diabetic nephropathyMing Yang, Chongbin Liu, Na Jiang, et al.
Frontiers in Cellular and Infection Microbiology|July 14, 2025
Intranasal trivalent candidate vaccine elicits broad humoral and cellular immunity against pneumococcal pneumoniaFangyu Ren, Luyun Huang, Shilu Luo, et al.
International Immunopharmacology|August 8, 2022
β-Hydroxybutyrate against Cisplatin-Induced acute kidney injury via inhibiting NLRP3 inflammasome and oxidative stressShilu Luo, Ming Yang, Yachun Han, et al.
Clinical Science (London, England : 1979)|May 25, 2023
DsbA-L alleviates tubular injury in diabetic nephropathy by activating mitophagy through maintenance of MAM integrityMing Yang, Qin Zhang, Shilu Luo, et al.
Pageof 5